Product Information
GABAPENTIN 400 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0400 per EA under NDC 31722015001. Its NADAC has been published 94 times since Nov 6, 2024.
FDA first approved this application on May 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722015001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA214956FDA Approved
5/10/2021
TE Code
AB
On Market Since
5/10/2021
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 400 MG CAPSULE has been published 94 times since Nov 6, 2024, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0400 per EA |
|---|---|
| All-time high | $0.0522 (Nov 13, 2024) |
| All-time low | $0.0396 (Apr 22, 2026) |
| 52-week high | $0.0445 |
| 52-week low | $0.0396 |
| Median price | $0.0420 |
| Average price | $0.0432 |
| Largest weekly change | -23.4% (Nov 20, 2024) |
| Weeks tracked | 94 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.0400 per EA (NDC 31722015001), effective Aug 19, 2026.
How has the price of GABAPENTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 23.4%. It has been tracked across 94 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?
Since Nov 6, 2024, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0396 (Apr 22, 2026) to a high of $0.0522 (Nov 13, 2024), with a median of $0.0420 per EA.
Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 400 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures GABAPENTIN 400 MG CAPSULE?
GABAPENTIN 400 MG CAPSULE (NDC 31722015001) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.